Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neoplasm
100%
Ovarian Cancer
86%
Cancer
77%
Uterine Cancer
65%
Malignant Neoplasm
60%
Pathologist
55%
Biopsy Technique
52%
Tumor
51%
Next Generation Sequencing
49%
Breast Cancer
45%
Fallopian Tube
44%
Optical Tomography
38%
Optical Coherence Tomography
37%
Krukenberg Tumor
36%
Diseases
32%
Endometrial Hyperplasia
29%
Genetics
28%
Chemotherapy
28%
Immunohistochemistry
27%
Gynecological Oncology
23%
Phase II Trials
22%
Photoacoustic Microscopy
22%
Breast Biopsy
22%
Breast Imaging - Reporting And Data System
22%
Targeted Therapy
21%
T Cell
20%
Metastatic Carcinoma
19%
Biological Marker
19%
Histopathology
18%
Treatment Response
18%
Serous Carcinoma
17%
Hemoglobin Determination
17%
Clear Cell Carcinoma
17%
Platinum
17%
Logistic Regression Analysis
17%
Hysterectomy
16%
Area under the Curve
16%
Estrogen Receptor
15%
Oncology
15%
Overall Survival
15%
Recurrent Disease
15%
Cancer Cell
14%
Head and Neck Cancer
14%
Pembrolizumab
14%
Thyroid Medullary Carcinoma
14%
DNA Damage
14%
Poly ADP Ribose Polymerase
14%
Estrogen
14%
Vascularity
14%
Gynecologic Pathology
13%
Keyphrases
Tumor
72%
Ovarian Cancer
62%
Endometrial Cancer
58%
Next-generation Sequencing
45%
Breast Cancer
30%
Optical Coherence Tomography
27%
Fallopian Tube
26%
Immunohistochemistry
25%
Metagenomic Next-generation Sequencing (mNGS)
24%
Endometrial Hyperplasia
23%
PARP Inhibitors (PARPi)
23%
Neoadjuvant
22%
Pathologists
21%
Cyclin-dependent Kinase 4 (CDK4)
21%
Replication Stress
18%
AXL Inhibition
17%
Histopathology
17%
Endometrioid
17%
Treatment Response
17%
Uterine Serous Cancer
17%
Gynecologic Oncology Group
16%
T Cells
16%
Carboplatin
16%
Molecular Pathology
16%
Tumor-infiltrating Lymphocytes
16%
Ultrasound-guided Diffuse Optical Tomography
16%
Clear Cell Carcinoma
16%
Primary Tumor
16%
Malignancy
15%
Gene Expression
15%
Targeted Therapy
15%
Chemotherapy
14%
Ovarian Carcinoma
14%
Phase II Trial
14%
Breast Biopsy
14%
DNA Damage
14%
Tissue-like
14%
Immune Monitoring
14%
Breast Cancer Susceptibility
14%
NRG Oncology
14%
Epigenetic Reprogramming
14%
Sensitivity to Chemotherapy
14%
HER2-negative Breast Cancer
14%
Anastrozole
14%
Cell Cycle Genes
14%
Deep Learning
14%
Mammaglobin
14%
Medullary Thyroid Carcinoma
14%
Hormonal Therapy
14%
OR-PAM
14%